ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1507

Predictors of Fatigue and Persistent Fatigue in Early Rheumatoid Arthritis: A Longitudinal Observational Study

Samantha Rodriguez-Muguruza1, Bernard Combe2, Francis Guillemin3, Bruno Fautrel4, Alejandro Olivé-Marqués5, Sara Marsal6, Oliver Valero7, Nathalie Rincheval8 and Cédric Lukas9, 1Rheumatology, Hospital Verge de la Cinta, Tarragona, Spain, 2Rheumatology, CHU Montpellier, Montpellier University, Montpellier, France, 3University of Lorraine, Nancy, France, Nancy, France, 4University Pierre et Marie Curie, Paris, France, 5Rheumatology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 6Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain, 7Servei d’estadística aplicada, Universitat Autonoma de Barcelona, Barcelona, Spain, 8EA2415, Montpellier, France, 9Rheumatology, Lapeyronie Hospital and EA2415 Montpellier University, Montpellier, France

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Fatigue and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Fatigue is a multifactorial and persistent symptom reported by patients with rheumatoid arthritis (RA). It is considered as frequent as pain. It would be of value to identify potential predictive factors of fatigue that could influence on its evolution.

Methods: The Etude et Suivi des polyarthrites Indifferenciees Récentes (ESPOIR) is a multicenter French cohort of patients with early arthritis. We selected patients fulfilling the 2010 ACR/EULAR criteria for RA during the first year of follow-up. We recorded fatigue (SF vitality score <=40), persistent fatigue (SF vitality score <=40 at the end of the study and at least in 50% of visits in the 5 years follow up) and disease variables at baseline and every 6 months up to 5 years. The association between fatigue/persistent fatigue and disease characteristics were evaluated by bivariate logistic regression models / tests. A multivariate logistic regression model was used to determine independent predictors of fatigue at baseline and persistent fatigue at 5 years of follow-up. Moreover, to analyse the association between the course of fatigue and disease characteristics over the time, baseline variables associated with fatigue at the multivariate analysis were analysed by a repeated measures logistic regression model at various time points (M12, M24, M36, M48 and M60).

Results:

We included 677 patients (73.4% women, mean ± SD age 48.6 ± 12 years); 46.5%, 28% and 22% of patients presented fatigue at baseline, 6 months and 5 years of follow up respectively. At baseline, fatigue was independently and significantly associated with single patients (OR = 2.5 95% CI [1.42-3.33] p <0.001), abnormal BMI (OR = 1.1 95% CI [1.01 – 1.10] p = 0.007), higher DAS28 (OR = 1.3 95% CI [1.08-1.60] p = 0.006), higher severity of morning stiffness (scored 0-10) (OR = 1.0 95% CI [1.00-1.01] p = 0.012), higher HAQ (OR = 2.4 95% CI [1.70-3.44] p <0.001), negativity of FR (OR = 1.5 95% CI [1.09-2.29] p = 0.016) and history of depression or anxiety (OR = 6.1 95% CI [3.90-9.83] p<0.001).

The most important predictors of fatigue over 5 years were disability (p<0.001) and depression/anxiety (p<0.001).

A 14.9% of patients presented persistent fatigue. Its independent predictors at 5 years of follow-up were HAQ (OR = 0.5 95% CI [1.66-3.73] p<0.001), history of depression/anxiety (OR = 3.6 95% CI [1.48-8.82] p = 0.005), >3 comorbidity (OR = 2.1 95% CI [1.18- 3.66] p = 0.010), dry syndrome (OR = 2.3 95% CI [1.39- 4.17] p = 0.002), and anti CCP negativity (OR = 1.96 95% CI [1.1-3.44] p = 0.021).

Conclusion: Fatigue was a frequent symptom in this cohort of early RA patient; its presence decreased at 6 months and remained stable over time. Baseline fatigue and persistent fatigue were both predicted by functional impairment and history of depression or anxiety. Disease activity measured by DAS28 was strongly associated to fatigue at baseline but it was not a predictor of persistent fatigue.


Disclosure: S. Rodriguez-Muguruza, None; B. Combe, None; F. Guillemin, None; B. Fautrel, None; A. Olivé-Marqués, None; S. Marsal, None; O. Valero, None; N. Rincheval, None; C. Lukas, None.

To cite this abstract in AMA style:

Rodriguez-Muguruza S, Combe B, Guillemin F, Fautrel B, Olivé-Marqués A, Marsal S, Valero O, Rincheval N, Lukas C. Predictors of Fatigue and Persistent Fatigue in Early Rheumatoid Arthritis: A Longitudinal Observational Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/predictors-of-fatigue-and-persistent-fatigue-in-early-rheumatoid-arthritis-a-longitudinal-observational-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-fatigue-and-persistent-fatigue-in-early-rheumatoid-arthritis-a-longitudinal-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology